GlassScriptPhysician profile
Ashit G Patel
NPI 1427276757
$36,102.91
in general payments reported to CMS, 2019-2025
44 companies · $4,694 in 2025
The $4,694 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,930 · 2020: $5,055 · 2021: $2,513 · 2022: $5,513 · 2023: $10K · 2024: $3,365 · 2025: $4,694.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,013 · Food and Beverage: $6,205 · Travel and Lodging: $4,832 · Education: $42.36.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,012.50 |
| Food and Beverage | $6,204.53 |
| Travel and Lodging | $4,832.46 |
| Education | $42.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17,046.98 | 2019-2025 | Advisor, Ensite, Aveir |
| Philips North America LLC | $9,352.05 | 2019-2023 | (9520) Igt Devices Undivided |
| Medtronic, INC. | $1,931.68 | 2021-2025 | Evera Mri Xt Dr Surescan, Attain Command + Surevalve, Cobalt Dr Mri Surescan |
| Biotronik INC. | $1,641.46 | 2019-2024 | Amvia Edge, Biomonitor, Acticor 7 Vr-T Dx |
| Boston Scientific Corporation | $1,102.33 | 2019-2025 | Watchman Access System, Watchman Flx, Watchman |
| Pfizer INC. | $652.90 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $558.36 | 2019-2025 | Eliquis, Camzyos |
| Biosense Webster, INC. | $401.76 | 2024 | Carto 3 |
| Amgen INC. | $331.37 | 2019-2025 | Repatha, Repatha |
| Merck Sharp & Dohme LLC | $328.83 | 2021-2025 | Verquvo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $299.56 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $296.56 | 2019-2025 | Farxiga, Lokelma |
| Janssen Pharmaceuticals, INC | $295.04 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $276.47 | 2019-2025 | |
| Medtronic Vascular, INC. | $234.95 | 2019-2020 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $185.00 | 2019 | |
| Allergan, INC. | $125.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $99.05 | 2024-2025 | Lifevest |
| Teleflex LLC | $88.01 | 2023 | Guideliner, Vsi, Vascband |
| Actelion Pharmaceuticals US, INC. | $79.74 | 2019-2025 | Uptravi |
| Cordis US Corp. | $67.55 | 2022-2025 | Mynx Control, Mynx Control Venous |
| Bayer Healthcare Pharmaceuticals INC. | $65.73 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $63.93 | 2019 | |
| Shockwave Medical, INC | $56.25 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Impulse Dynamics (USA) INC. | $55.61 | 2022-2024 | Optimizer |
| Novo Nordisk INC | $52.48 | 2025 | Wegovy |
| Alnylam Pharmaceuticals INC. | $48.59 | 2023-2025 | Amvuttra |
| Cardiva Medical, INC. | $38.94 | 2021 | |
| Irhythm Technologies, INC. | $28.71 | 2020-2021 | |
| Portola Pharmaceuticals, LLC | $27.75 | 2019 | |
| Bardy Diagnostics, INC. | $27.50 | 2021 | |
| Kiniksa Pharmaceuticals, LTD. | $24.13 | 2023 | Arcalyst |
| Cardinal Health 200 LLC | $23.64 | 2021 | |
| Cvrx, INC. | $22.94 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $20.83 | 2021 | |
| Celgene Corporation | $20.19 | 2024 | Eliquis |
| Altathera Pharmaceuticals LLC | $19.41 | 2024 | Sotalol Hydrochloride |
| Chiesi USA, INC. | $18.10 | 2023 | Cleviprex, Kengreal |
| Regeneron Healthcare Solutions, INC. | $17.24 | 2019 | |
| Lundbeck LLC | $16.79 | 2019 | |
| Ekos Corporation | $16.19 | 2019 | |
| Scpharmaceuticals INC. | $14.73 | 2023 | |
| Esperion Therapeutics, INC. | $14.62 | 2021 | |
| Opsens INC. | $13.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashit Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.